MGC Diagnostics Corporation (NASDAQ: MGCD), is a global medical
technology company dedicated to cardiorespiratory health solutions.
The Company, through its subsidiary Medical Graphics Corporation,
develops, manufactures and markets non-invasive diagnostic systems.
This portfolio of products provides solutions for disease
detection, integrated care, and wellness across the spectrum of
cardiorespiratory healthcare. The Company's products are sold
internationally through distributors and in the United States
through a direct sales force targeting heart and lung specialists
located in hospitals, university-based medical centers, medical
clinics, physicians' offices, pharmaceutical companies, medical
device manufacturers, and clinical research organizations (CROs).
For more information about MGC Diagnostics, visit